ABVC Biopharma, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
9.50
|
|
Average Rating
|
3.00
|
|
# Strong Buys
|
0
|
|
# Buys
|
0
|
|
# Holds
|
1
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.12
|
-0.06
|
0.06
|
50.00%
|
|
2022-06-30
|
-0.12
|
-0.06
|
0.06
|
50.00%
|
|
2022-03-31
|
-0.20
|
-0.20
|
0.00
|
0.00%
|
|
2021-12-31
|
-0.04
|
-0.31
|
-0.27
|
-675.00%
|
|
2021-09-30
|
-0.04
|
-0.07
|
-0.03
|
-75.00%
|
|
2021-06-30
|
-0.04
|
-0.08
|
-0.04
|
-100.00%
|
|
2021-03-31
|
0.00
|
-0.05
|
0.00
|
0.00%
|
|
2020-12-31
|
-0.10
|
-0.24
|
-0.14
|
-140.00%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-0.32
|
|
2021-12-31
|
-0.51
|
|
2020-12-31
|
-0.51
|
|
2019-12-31
|
-0.22
|
|
2018-12-31
|
-0.47
|
|
2017-12-31
|
-0.46
|
|
2016-12-31
|
-1.11
|
|
2015-12-31
|
-1.15
|
|
2014-12-31
|
-0.57
|
|
2013-12-31
|
-77.10
|
|
2012-12-31
|
-1460.92
|
|
2011-12-31
|
-7957.27
|
|
2010-12-31
|
-8060.53
|
|
2009-12-31
|
-18004.89
|
|
2008-12-31
|
-53755.22
|
|
2006-12-31
|
-5054.92
|
|
2004-12-31
|
-574.39
|